Anna R.

Anna R. is a highly experienced regulatory affairs professional with expertise in managing international product registrations and regulatory compliance across various regions. Currently serving as a Staff Regulatory Affairs Specialist at BD since November 2022, Anna leads regulatory efforts for cross-functional teams and conducts assessments for product changes. Previous roles include Senior Regulatory Affairs Specialist at Cepheid, where Anna handled registrations for over 30 IVD products in multiple countries, and Regulatory Affairs Manager at Spacelabs Healthcare, overseeing regulatory filings in over 90 territories. Additional experience includes roles at NanoString Technologies Inc., Adaptive Biotechnologies Corp., and the University of Washington, with a strong background in molecular diagnostics and regulatory strategies. Anna holds a Master of Science in Molecular Biology from the Weizmann Institute of Science and a certification in Biomedical Regulatory Affairs from the University of Washington, along with degrees in Computer Systems and Biology.